Search results
Sun Pharma open to exploring acquisitions in global specialty portfolio
Business Standard India· 4 days agoSun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline
Nifty Pharma up 48% in the last 1 year; Zydus, Lupin, Glenmark surge over 95% each; what is driving...
Livemint· 5 days agoThe Nifty Pharma index hit a fresh 52-week high of 20,575.35 in intraday trade on Monday, July 8....
India set to witness obesity pill revolution? As patents near expiry, pharma giants gear up for...
Financial Express· 5 days agoBlockbuster obesity drugs like Ozempic and Wegovy have become a global sensation. Now the Indian...